Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polyme...
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
About this item
Full title
Author / Creator
Gabert, J , Beillard, E , van der Velden, V H J , Bi, W , Grimwade, D , Pallisgaard, N , Barbany, G , Cazzaniga, G , Cayuela, J M , Cavé, H , Pane, F , Aerts, J L E , De Micheli, D , Thirion, X , Pradel, V , González, M , Viehmann, S , Malec, M , Saglio, G and van Dongen, J J M
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Detection of minimal residual disease (MRD) has proven to provide independent prognostic information for treatment stratification in several types of leukemias such as childhood acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and acute promyelocytc leukemia. This report focuses on the accurate quantitative measurement of fusion g...
Alternative Titles
Full title
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71463222
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71463222
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/sj.leu.2403135
